DHR

Danaher Corporation [DHR] Stock Forecast

Q: What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock, located in Washington of Dc and trading under the symbol DHR

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

DHR Stock Summary

DHR has more than 44 years of cash runway (537 months)

Earnings are expected to fall -100% next year

Top 10 Correlated ETFs

DHR

Top 10 Correlated Stocks

DHR

In the News

DHR Financial details

Company Rating

Buy

Market Cap

177.69B

Income

4.76B

Revenue

23.89B

Book val./share

72.3

Cash/share

7.93

Dividend

1.05

Dividend %

0.43%

Employees

61K

Optionable

Shortable

Yes

Earnings

23 Apr 2024

P/E

37.93

Forward P/E

PEG

-11.1

P/S

7.57

P/B

3.38

P/C

29.81

P/FCF

31.29

Quick Ratio

1.18

Current Ratio

1.68

Debt / Equity

0.37

LT Debt / Equity

0.33

EPS (TTM)

6.45

EPS next Y

EPS next Q

EPS this Y

-34.29%

EPS next Y

EPS next 5Y

EPS last 5Y

13.1%

Revenue last 5Y

5.93%

Revenue Q/Q

-60.82%

EPS Q/Q

-4.58%

SMA20

-4.19%

SMA50

-0.2%

SMA100

14.95%

Inst Own

60.54%

Inst Trans

0.78%

ROA

ROE

ROC

0.06%

Gross Margin

59%

Oper. Margin

20%

Profit Margin

20%

Payout

26%

Shs Outstand

Shs Float

Target Price

52W Range

182.09-259.0

52W High

-8.74%

52W Low

+29.87%

RSI

33.85

Rel Volume

1.6

Avg Volume

2.65M

Volume

4.24M

Perf Week

-5.38%

Perf Month

-6.54%

Perf Quarter

22.69%

Perf Half Y

11.52%

Beta

0.86

Volatility

2.92%, 5.34%

Prev Close

-1.27%

Price

236.36

Change

-1.69%

DHR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	25.05	31.55	41.22	43.4	32.44
Net income per share	4.21	5.16	9	9.94	6.47
Operating cash flow per share	5.53	8.79	11.7	11.75	9.73
Free cash flow per share	4.64	7.67	9.89	10.16	7.85
Cash per share	27.85	8.55	3.62	8.27	7.96
Book value per share	42.34	56.31	63.21	69.07	72.62
Tangible book value per share	-3.05	-23.97	-26.38	-13.74	-12.04
Share holders equity per share	42.34	56.31	63.21	69.07	72.62
Interest debt per share	30.54	30.41	31.37	27.43	26.91
Market cap	97.27B	139.06B	208.4B	170.59B	170.38B
Enterprise value	99.09B	154.23B	227.99B	184.28B	184.05B
P/E ratio	32.33	38.14	32.4	23.66	35.76
Price to sales ratio	5.43	6.24	7.08	5.42	7.13
POCF ratio	24.61	22.4	24.93	20.03	23.78
PFCF ratio	29.33	25.67	29.5	23.16	29.47
P/B Ratio	3.21	3.5	4.61	3.41	3.19
PTB ratio	3.21	3.5	4.61	3.41	3.19
EV to sales	5.53	6.92	7.74	5.86	7.7
Enterprise value over EBITDA	21.49	25.22	22.57	17.18	23.73
EV to operating cash flow	25.07	24.84	27.28	21.63	25.69
EV to free cash flow	29.88	28.47	32.27	25.01	31.84
Earnings yield	0.03	0.03	0.03	0.04	0.03
Free cash flow yield	0.03	0.04	0.03	0.04	0.03
Debt to equity	0.72	0.53	0.49	0.39	0.37
Debt to assets	0.35	0.28	0.27	0.23	0.23
Net debt to EBITDA	0.39	2.48	1.94	1.28	1.76
Current ratio	5.19	1.86	1.43	1.89	1.68
Interest coverage	30.1	15.39	31.37	41.18	18.19
Income quality	1.62	1.7	1.32	1.18	1.7
Dividend Yield	0.01	0	0	0	0.01
Payout ratio	0.25	0.17	0.12	0.11	0.26
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.06	0.06	0.06	0.06	0.06
Intangibles to total assets	0.52	0.74	0.77	0.71	0.74
Capex to operating cash flow	-0.16	-0.13	-0.15	-0.14	-0.19
Capex to revenue	-0.04	-0.04	-0.04	-0.04	-0.06
Capex to depreciation	-0.53	-0.45	-0.6	-0.52	-0.64
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	63.31	80.88	113.15	124.3	102.81
ROIC	0.05	0.06	0.09	0.11	0.06
Return on tangible assets	0.1	0.19	0.34	0.3	0.22
Graham Net	-12.14	-37.06	-42.77	-31.75	-28.37
Working capital	20.66B	6.4B	3.51B	7.49B	5.66B
Tangible asset value	-2.18B	-16.93B	-18.85B	-9.96B	-8.86B
Net current asset value	-6.2B	-22.58B	-26.36B	-18.38B	-17.06B
Invested capital	0.72	0.53	0.49	0.39	0.37
Average receivables	3.34B	3.62B	4.34B	4.77B	4.42B
Average payables	1.61B	1.78B	2.31B	2.43B	2.03B
Average inventory	1.77B	1.96B	2.53B	2.94B	2.85B
Days sales outstanding	65.04	66.25	57.39	57.04	59.92
Days payables outstanding	69.73	76.24	81.53	66.93	65.4
Days of inventory on hand	74.97	85.29	87.81	90.65	96.06
Receivables turnover	5.61	5.51	6.36	6.4	6.09
Payables turnover	5.23	4.79	4.48	5.45	5.58
Inventory turnover	4.87	4.28	4.16	4.03	3.8
ROE	0.1	0.09	0.14	0.14	0.09
Capex per share	-0.89	-1.12	-1.81	-1.59	-1.88

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-29	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	11.48	9.83	9.71	9.3	3.64
Net income per share	3.06	1.99	1.5	1.53	1.46
Operating cash flow per share	3.49	2.67	2.61	2.26	2.19
Free cash flow per share	3.03	2.29	2.15	1.77	1.65
Cash per share	8.22	10.12	11.63	16.6	7.93
Book value per share	68.71	70.58	70.14	70.88	72.3
Tangible book value per share	-13.67	-11.44	-9.72	-7.47	-11.98
Share holders equity per share	68.71	70.58	70.14	70.88	72.3
Interest debt per share	27.08	27.28	27.05	29.93	26.51
Market cap	171.49B	162.96B	156.85B	162.61B	171.15B
Enterprise value	185.17B	175.41B	168.15B	172.39B	184.82B
P/E ratio	19.21	28.1	35.46	36.01	39.65
Price to sales ratio	20.49	22.74	21.92	23.66	63.55
POCF ratio	67.49	83.7	81.44	97.25	105.71
PFCF ratio	77.53	97.46	98.96	124.41	140.63
P/B Ratio	3.42	3.17	3.03	3.1	3.2
PTB ratio	3.42	3.17	3.03	3.1	3.2
EV to sales	22.13	24.47	23.49	25.08	68.63
Enterprise value over EBITDA	82.04	73.06	115.25	83.2	150.38
EV to operating cash flow	72.87	90.09	87.31	103.11	114.16
EV to free cash flow	83.71	104.91	106.09	131.9	151.86
Earnings yield	0.01	0.01	0.01	0.01	0.01
Free cash flow yield	0.01	0.01	0.01	0.01	0.01
Debt to equity	0.39	0.39	0.38	0.42	0.37
Debt to assets	0.23	0.23	0.23	0.25	0.23
Net debt to EBITDA	6.06	5.19	7.75	4.72	11.12
Current ratio	1.89	1.89	2.08	2.26	1.68
Interest coverage	26.44	26.38	13.39	19.7	6.94
Income quality	1.14	1.34	1.74	1.48	3.02
Dividend Yield	0	0	0	0	0
Payout ratio	0.09	0.14	0.2	0.18	0.58
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.05	0.06	0.06	0.06	0.09
Intangibles to total assets	0.71	0.7	0.69	0.66	0.74
Capex to operating cash flow	-0.13	-0.14	-0.18	-0.22	-0.25
Capex to revenue	-0.04	-0.04	-0.05	-0.05	-0.15
Capex to depreciation	-0.58	-0.49	-0.61	-0.66	-0.82
Stock based compensation to revenue	0.01	0.01	0.02	0.01	0.01
Graham number	68.8	56.18	48.66	49.35	48.71
ROIC	0.02	0.02	0.01	0.02	0.01
Return on tangible assets	0.09	0.06	0.04	0.04	0.05
Graham Net	-31.58	-29.13	-26.94	-24.86	-28.24
Working capital	7.49B	7.8B	9.06B	11.84B	5.66B
Tangible asset value	-9.96B	-8.35B	-7.17B	-5.53B	-8.86B
Net current asset value	-18.38B	-17.02B	-15.72B	-14.11B	-17.06B
Invested capital	0.39	0.39	0.38	0.42	0.37
Average receivables	4.66B	4.62B	4.26B	4.2B	4.06B
Average payables	2.24B	2.19B	2.02B	1.93B	1.83B
Average inventory	3.17B	3.25B	3.28B	3.1B	2.81B
Days sales outstanding	52.89	54.16	52.8	55.01	131.07
Days payables outstanding	60.24	66.96	56.5	59.33	148.54
Days of inventory on hand	81.6	108.86	91.94	94.73	218.19
Receivables turnover	1.7	1.66	1.7	1.64	0.69
Payables turnover	1.49	1.34	1.59	1.52	0.61
Inventory turnover	1.1	0.83	0.98	0.95	0.41
ROE	0.04	0.03	0.02	0.02	0.02
Capex per share	-0.45	-0.38	-0.46	-0.49	-0.54

DHR Dividend History

DHR Frequently Asked Questions

What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol DHR

What is Danaher Corporation stock quote today ?

Danaher Corporation stock price is $236.36 today.

Is Danaher Corporation stock public?

Yes, Danaher Corporation is a publicly traded company.

Something similar

Top by Market Cap

Company Profile

Volume Average 2.65M
Market Capitalization 177.69B
Employee 61K
CEO Mr. Rainer M. Blair
Headquarters Washington,DC,US
IPO Date 1978-12-29
Website https://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.